RxSight Shares Fall 38% on Q2 ‘Underperformance’
Shares of RxSight Inc. tumbled 38% in the trading session after the cataract lens maker reported disappointing preliminary second quarter results July 8. The Aliso Viejo-based company reported expected second quarter revenue of about $33.6 million, missing analysts’ expectations of $39.8 million. It also decreased 2025 revenue guidance to $120 Read More